Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon
I Can Extract Side Effects
Chapter 350

This Bone Resorption Inhibitor Should Come in Handy for You (Part 2)

1,474 words 5 min read 1 view 3mo ago Source ​
Skip to the end of the chapter
Prev
Next

Wei Kang also saw the news about NASA online, but he didn't take it to heart, finding it somewhat ridiculous.

He suddenly felt like his eyes had been opened; it turned out that bureaucrats all over the world had pretty much the same face when they were trying to swindle funding.

It's no secret that many institutions in the Eagle Country purchase equipment from the East, then refurbish it, giving it a veneer of compliance in terms of appearance and branding, and use it openly.

It's unbelievable that NASA, a self-proclaimed temple of technology, has also fallen into depravity, no different from other organizations, engaging in this deceptive practice of falsely claiming technology as their own. It's utterly laughable.

Thinking of this, he couldn't help but shake his head in disappointment. Compared to the China Aerospace Center, this NASA was far inferior. It couldn't even be realistic. How could it roam the ocean of science and technology and reach the Starry Sea?

Just then, my phone rang.

Upon closer inspection, it was Fang Heng from the Aerospace Center.

Fang Heng came to deliver good news. "President Wei, great news! The Portable Universal Patient Monitor has been a great success. The Aerospace Center wants to establish a long-term strategic partnership with Three Purities. In the future, we will strengthen cooperation in the field of space medicine, whether it is drugs or equipment."

Wei Kang was very happy to hear this. It was indeed good news. In this way, any medical devices developed in the future could be displayed and promoted directly on the Space Station. At the same time, it would also be more closely linked to the country's aerospace field. For Three Purities, this would be entirely beneficial.

It's not so obvious when there's only one device, but as more medical devices are developed in the future, especially some advanced and large-scale equipment, being able to test them in a place like Space Station will give people a much stronger impression than testing them in a hospital.

If the results are good, it will serve as an endorsement, making it more convincing when promoted to other public hospitals in the future.

So they immediately agreed, and then the two sides discussed in-depth cooperation in the pharmaceutical field.

Due to factors such as strong radiation, weightlessness, and storage conditions in space, the efficacy of many drugs decreases significantly after a space journey, and many drugs fail to meet the prescribed efficacy requirements.

Correspondingly, the shelf life is also greatly reduced, generally to 6-12 months, which is much shorter than the shelf life of ordinary drugs, which is often two or three years.

In the Space Station, the activity of many bacteria and viruses is often greatly enhanced, and they may even undergo certain mutations.

Therefore, the Aerospace Center wants to conduct research in medicine and genetics with Three Purities.

Not only can we extend the efficacy and shelf life of some common drugs, but we can also use the space environment to study the genetic variations of organisms.

Sanqing Group has an excellent reputation in the manufacturing and R&D of original drugs and generic drugs, making it the best partner for cooperation. Not to mention, many of these drugs are produced by Three Purities itself.

As for the biological field, the new Gene Editing Technology and Gene Therapy are both strengths of Three Purities.

"Due to the needs of space travel, such as a three-year trip to Mars and the future construction of a lunar base, our current frequent resupply model for medicines is not realistic. We must take into account the long-term demand for medicines and strive to achieve self-sufficiency in space as much as possible."

"Currently, the shelf life of most drugs on the market cannot meet the requirements of space travel. On-demand drug production in space may be the best solution to this challenge."

"Therefore, we plan to start with some of the simplest drugs and study the effects of microgravity environment and space radiation on the stability of the tablet formulation. Radiation protection will be incorporated into the design of the tablet."

Fang Heng spoke eloquently, revealing all the plans for the Aerospace Center.

"The first batch of drugs not only contains active ingredients such as Ibuprofen and vitamin C, but also excipients such as silicon dioxide, magnesium silicate and calcium phosphate, which can all be found on the surface of the moon."

"Our plan is to understand the impact of changes on drug stability by altering the interactions between the ingredients and the drug."

"Collecting data on drug stability for long-duration space missions will help with on-demand drug production in orbit in the future."

"This is an 'Automated Onboard Drug Manufacturing' project. It has just been approved and has not yet officially started. However, with your participation, it will surely be a great help and progress will be rapid."

Wei Kang's mind was suddenly stirred. The unique microgravity environment of the Space Station could enable some scientific research that is limited by Earth's gravity to develop and thus achieve new breakthroughs.

This is equally important for the life sciences and biotechnology fields.

During its more than 20 years in orbit, the International Space Station conducted approximately 3,000 scientific studies across various disciplines, with biological sciences accounting for the largest proportion.

Unfortunately, China was completely isolated from this research field in the past.

It has neither Space Station nor pharmaceutical giants, and lacks the conditions to conduct research in the fields of space medicine and biology.

Now, with Sanqing Pharmaceutical and the Tiangong Space Station, the conditions are very mature, and we can catch up and accelerate research in the field of life sciences in space.

Not only is it worth exploring in the field of biology, but even some blockbuster new drugs have benefited from space experiments.

Many macromolecular drugs face numerous technical challenges in manufacturing, delivery, and storage, which are expected to be addressed by improving crystallization and purification techniques.

Merck researchers have collaborated with the International Space Station to conduct crystallization experiments using macromolecular drugs during commercial resupply missions.

They used microgravity experiments to study the effects of sedimentation rate and temperature gradient on crystallization purification.

The results showed that under microgravity conditions, sedimentation and convection decreased, resulting in a crystallized suspension with lower viscosity and greater uniformity than the ground-based control group.

Later, the research team used a rotary mixer to control variables such as sedimentation rate and temperature gradient to induce nucleation and control crystallization, and successfully replicated the uniform crystalline suspension in space in ground experiments.

This is of great significance for the purification and storage of macromolecular drugs. If it can be widely applied, macromolecular drugs will be changed from intravenous injection to subcutaneous injection, which can greatly improve the quality of life of patients.

In addition, the space environment can provide meaningful data for clinical trials, provide a comparison for trials on the ground, and serve as a perfect reference.

He now has a new drug on hand that is perfectly suited to the physical problems caused by the space environment.

Thinking of this, Wei Kang glanced at the table and picked up an experimental report.

This is Phase I Clinical Trial report for a bone resorption inhibitor.

Data shows that this new drug can inhibit bone resorption and has a strong therapeutic effect on Osteoporosis and related diseases.

And no one understands Osteoporosis better than astronauts.

In space, astronauts are exposed to microgravity for extended periods, which causes a series of changes in their bodies and can trigger some potential diseases, the most prominent of which is Osteoporosis.

Under normal circumstances, the bones maintain a balance of bone mass through the interaction of bone formation and bone resorption.

However, in a microgravity environment, because the bones no longer need to resist the effects of gravity, the reduced load leads to increased bone resorption, which in turn causes Osteoporosis.

While physical exercise can alleviate the risk, it cannot completely eliminate it.

The whole process is very fast, often causing Osteoporosis in astronauts in just a few weeks, unlike on Earth where Osteoporosis is rare in young people and mostly occurs in the elderly.

Without a doubt, strong and healthy astronauts with high recovery rates would be very suitable test subjects.

The space environment is also a perfect site for clinical trials.

Healthy people may develop Osteoporosis symptoms within a few weeks of starting the medication, and they can monitor the medication's effectiveness while taking it.

You can recover quickly afterward, so there's no need to worry about any aftereffects.

Isn't this much stronger than a 60-year-old woman?

The moment the idea popped into his head, Wei Kang said it aloud into his phone.

He was certain that the other party would be interested.

"There is a new drug, an Osteoporosis, which I think you can use."

"Would your astronauts be willing to give it a try?"

The 5,000-word chapter was blocked, and I can only apply for unblocking it after 48 hours, so I split it into two chapters to post.

End of Chapter
Prev
NovelSummaries
Next

Explore the wiki

Wei Kang
Three Purities
China
Eagle Country

Comments

No comments yet.
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS